Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2026-03-13 @ 3:22 PM
Study NCT ID:
NCT05130866
Status:
TERMINATED
Last Update Posted:
2025-10-07
First Post:
2021-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
Sponsor:
Recursion Pharmaceuticals Inc.
Organization: